Regression of metastatic, radiation/chemotherapy-resistant uterine serous carcinoma overexpressing HER2/neu with trastuzumab emtansine (TDM-1)

by Alessandro D. Santin, Stefania Bellone, Natalia Buza, Peter E. Schwartz
Published 2017-02-01

Clear Cell Cancer of the Uterine Corpus: The Association of Clinicopathologic Parameters and Treatment on Disease Progression

by Joyce Varughese, Pei Hui, Lingeng Lu, Herbert Yu, Peter E. Schwartz
Published 2011-01-01

Correction of coagulopathy associated with non-bacterial thrombotic endocarditis (NBTE) by surgical debulking in a case of ovarian clear cell carcinoma

by Benjamin B. Albright, Jonathan D. Black, Nicole Vilardo, Peter E. Schwartz
Published 2016-08-01

Binimetinib (MEK162) in recurrent low-grade serous ovarian cancer resistant to chemotherapy and hormonal treatment

by Chanhee Han, Stefania Bellone, Luca Zammataro, Peter E. Schwartz, Alessandro D. Santin
Published 2018-08-01

Sacituzumab Govitecan (IMMU-132) in treatment-resistant uterine serous carcinoma: A case report

by Chanhee Han, Stefania Bellone, Peter E. Schwartz, Serengulam V. Govindan, Robert M. Sharkey, David M. Goldenberg, Alessandro D. Santin
Published 2018-08-01

Selection of HER2/NEU negative tumor cells as a mechanism of resistance to trastuzumab in uterine serous carcinoma

by Silvia Pelligra, Natalia Buza, Pei Hui, Stefania Bellone, Burak Zeybek, Elena Ratner, Peter E. Schwartz, Giovanni Scambia, Alessandro D. Santin
Published 2020-05-01

Associated characteristics and impact on recurrence and survival of free-floating tumor fragments in the lumen of fallopian tubes in Type I and Type II endometrial cancer

by Benjamin B. Albright, Jonathan D. Black, Rachel Passarelli, Stefan Gysler, Margaret Whicker, Gary Altwerger, Gulden Menderes, Natalia Buza, Pei Hui, Alessandro D. Santin, Masoud Azodi, Dan-Arin Silasi, Elena S. Ratner, Babak Litkouhi, Peter E. Schwartz
Published 2018-02-01

Prescribed medical cannabis in women with gynecologic malignancies: A single-institution survey-based study

by Emily M. Webster, Ghanshyam S. Yadav, Stefan Gysler, Blair McNamara, Jonathan Black, Joan Tymon-Rosario, Burak Zeybek, Chanhee Han, Christopher K. Arkfeld, Vaagn Andikyan, Gulden Menderes, Gloria Huang, Masoud Azodi, Dan-Arin Silasi, Alessandro D. Santin, Peter E. Schwartz, Elena S. Ratner, Gary Altwerger
Published 2020-11-01

Sacituzumab govitecan, an antibody‐drug conjugate targeting trophoblast cell‐surface antigen 2, shows cytotoxic activity against poorly differentiated endometrial adenocarcinomas i...

by Emanuele Perrone, Paola Manara, Salvatore Lopez, Stefania Bellone, Elena Bonazzoli, Aranzazu Manzano, Luca Zammataro, Anna Bianchi, Burak Zeybek, Natalia Buza, Joan Tymon‐Rosario, Gary Altwerger, Chanhee Han, Gulden Menderes, Gloria S. Huang, Elena Ratner, Dan‐Arin Silasi, Masoud Azodi, Pei Hui, Peter E. Schwartz, Giovanni Scambia, Alessandro D. Santin
Published 2020-03-01

Preclinical Activity of Sacituzumab Govitecan, an Antibody-Drug Conjugate Targeting Trophoblast Cell-Surface Antigen 2 (Trop-2) Linked to the Active Metabolite of Irinotecan (SN-38...

by Emanuele Perrone, Emanuele Perrone, Salvatore Lopez, Salvatore Lopez, Burak Zeybek, Stefania Bellone, Elena Bonazzoli, Silvia Pelligra, Luca Zammataro, Aranzazu Manzano, Paola Manara, Anna Bianchi, Natalia Buza, Joan Tymon-Rosario, Gary Altwerger, Chanhee Han, Gulden Menderes, Elena Ratner, Dan-Arin Silasi, Masoud Azodi, Pei Hui, Peter E. Schwartz, Giovanni Scambia, Alessandro D. Santin
Published 2020-02-01